← Leaderboards
Tapas K Makar
University Of Maryland Baltimore
$204,375
Attributed
$408,750
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $225K · FY2010–17$250K$187.5K$125K$62.5K$0
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$408,750 · 1
VA$0 · 1
By mechanism
R21$408,750 · 1
I01$0 · 1
Top collaborators
- Walter Royal2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Zubair M. Ahmed$12,184,490
- Lisa D Coles$1,848,365
- Jessica Mong$10,137,251
- Nigel T Maidment$12,633,034
- Mervyn J Monteiro$14,914,800
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBrainMediatingSymptomsNeuronsImmuneExperimental Autoimmune EncephalomyelitisInflammationNeurologicProtective EffectBasePreventNerve DegenerationBrain-Derived Neurotrophic FactorBone Marrow Stem CellPublic Health RelevanceBlood - Brain Barrier AnatomyBehavioralAnti-Inflammatory AgentsBehaviorCalcium-Binding ProteinsAnti-InflammatoryAnimal Disease ModelsAstrocytes
Grant awards (4)
BDNF agonist treatment in experimental allergic encephalomyelitis$0
I01 · FY2017 · VA · contact PI
BDNF agonist treatment in experimental allergic encephalomyelitis$0
I01 · FY2016 · VA · contact PI
A Model of Stem Cell-Based Treatment of HIV-Related Neurological Disease$183,750
R21 · FY2011 · NS
A Model of Stem Cell-Based Treatment of HIV-Related Neurological Disease$225,000
R21 · FY2010 · NS